Treat every EBITDA add-back as a claim to prove
The strongest schedule does not contain the most positive adjustments. It makes the source, sign, recurrence, offsets, future operating cost, and unresolved judgment visible for every line.
What determines value
An EBITDA add-back is a proposed adjustment to reported earnings, not an automatic increase in value. A supportable workpaper ties the signed amount to source records, tests whether the operating cause recurs, includes related offsets and future replacement costs, and leaves transaction treatment explicitly unresolved.
Start with one source period and one row per proposed adjustment. 123
On this page 9 sections
An EBITDA add-back is a claim, not a value increase
An EBITDA add-back is a proposed adjustment to reported earnings, not an automatic increase in value. It asks a reviewer to consider whether a recorded expense should be treated differently for a stated purpose. The label alone does not prove the amount, recurrence, future operating cost, transaction treatment, or value. 12
The IBBA glossary defines add-backs as expenses added to net income in an effort to approach economic earnings. Its adjusted-EBITDA definition also includes a replacement-cost concept for an owner's functions. Those are communication definitions, not evidence that an item qualifies or that a buyer must accept it. 1
SEC staff guidance applies to registrant disclosure, not a private-company sale. Its controls are still useful guardrails: call a measure calculated differently from EBITDA by a distinguishing name, reconcile it, treat irregularly occurring operating costs as potentially recurring, and explain inconsistent treatment across periods. 2
The SEC's Regulation G release similarly centers a comparable reported measure and a clearly understandable quantitative reconciliation for covered public disclosures. This guide borrows that record discipline without claiming the rule governs a private transaction. The source statement should remain visible beside the proposed bridge. 3
Keep three questions separate. Did the amount occur? Does the source support the signed number? Should the amount be treated differently for this purpose? The first two can be resolved by records. The third remains an analysis that depends on the business, period, operating model, and use.
Before adding normalization rows reconcile the earnings basis firstso reported EBITDA adjusted EBITDA and SDE remain distinct.
Terms used in this guide
- Add-back
- A proposed expense adjustment intended to move reported income toward a stated economic-earnings view under the cited brokerage definition; it is not accepted treatment or value by itself. 1
- Reported EBITDA
- Net income before interest taxes depreciation and amortization under the cited SEC terminology, without the additional proposed normalization rows discussed here. 2
- Treatment status
- The current review disposition for a proposed line, such as evidence gap or treatment open; it is intentionally separate from the signed arithmetic amount.
Build the source bridge before debating treatment
A proposed add-back becomes reviewable when its amount reconciles to the same source period, the underlying event and business purpose are documented, similar prior or future costs are tested, related income and expenses are netted, and the future operating counterfactual is stated. Those controls support analysis; they do not compel a buyer to accept the line. 2456
Start with the general-ledger account, source statement, and reporting period. Record the proposed signed effect: a positive adjustment, a negative correction, or zero while evidence is missing. Then attach the invoice, payroll record, contract, bank proof, or other document that supports the amount and date.
Current IRS recordkeeping guidance says expense support should identify the payee, amount, proof of payment, date incurred, and business description. That standard addresses federal tax records, not transaction treatment, but it provides a concrete source checklist. A memo without the underlying record is not an adequate bridge. 5
Publication 583 also emphasizes consistent accounting periods, source identification, journals, ledgers, account descriptions, and controls over retained records. Keep the adjustment period aligned with the source financials. If a run-rate or later event is relevant, place it in a separate labeled column rather than rewriting history. 6
IVS frames valuation as structured judgment supported by purpose, basis, data inputs, model responsibility, documentation, limitations, and uncertainty. The practical consequence is that a clean subtotal cannot validate weak inputs. Record who supplied each line, who checked it, what remains uncertain, and the use for which it was prepared. 4
- Record the source account statement and exact period.
- Use a signed amount for additions and deductions.
- Attach invoices payroll contracts and payment evidence.
- State the event business purpose and responsible owner.
- Pair related income costs credits and recoveries.
- Preserve the question and current treatment status.
Recurrence follows the operating cause, not the account label
Do not call a cost nonrecurring because it appeared once in the selected year. Search prior periods, adjacent accounts, open commitments, board or management plans, and the event's root cause. A litigation invoice, relocation charge, recruiting fee, outage cost, or consulting project can be singular, repeated, or part of an ongoing condition.
SEC staff says that an operating expense can be recurring even when it repeats only occasionally or at irregular intervals in its public-company disclosure context. It also flags adjusting one period while leaving similar items untreated in another. The private-company lesson is narrow: use comparable periods and a written adjustment policy. 2
Test the operating cause. A one-time invoice for a permanent compliance requirement may precede recurring costs. A repeated charge may genuinely end with a completed contract. A terminated lease can produce a cost that disappears, while the replacement site creates a different ongoing expense. The ledger label cannot answer those questions.
Search for countervailing items at the same time. Insurance recoveries, vendor credits, settlement proceeds, rebates, and capitalized costs can share an event with the proposed expense. Show gross lines when helpful, but state the signed net effect and why each related item belongs or does not belong. 34
Apply the same discipline to downward corrections. Missing management capacity, deferred maintenance, an unrecorded market-rate lease, or income treated inconsistently with the expense base may reduce the proposed subtotal. This is not a directive to make any adjustment; it is a completeness test.
Decision table
Swipe to compare| Workpaper gate | Record to preserve | Question that remains |
|---|---|---|
| Source | Ledger line, statement period, invoice or payroll, and payment proof | Does the signed amount reconcile exactly? |
| Recurrence | Prior periods, similar accounts, commitments, and root-cause memo | Will the operating cause recur or change form? |
| Counterfactual | Role map, contract, capacity plan, and replacement-cost support | What cost exists if this line is removed? |
| Offsets | Recoveries, credits, related income, and downward corrections | What is the complete signed net effect? |
| Disposition | Reviewer, date, rationale, limitation, and version history | Is treatment supported, open, or removed for this purpose? |
A fictional workpaper shows why signed rows and offsets matter
Hypothetical example — not market evidence, an accepted adjustment, a valuation conclusion, or a forecast. North Harbor Components is fictional. Every amount, event, account, source description, status, and operating assumption below was created only to demonstrate workpaper controls.
The first fictional row proposes adding $24,000 of incident cost. Invoices and payment proof support the expense, but a related $6,000 recovery and a prior similar event are visible. The signed net proposal is $18,000, and treatment remains open while recurrence and event scope are reviewed.
The second row proposes adding $18,000 of owner vehicle expense. The lease and card records support the amount, but the mileage and business-use split are incomplete. The current status is evidence gap. The schedule does not add back the full account merely because the owner uses the vehicle.
The third row records a negative $30,000 capacity question. A role map indicates recurring controller work not fully represented in the source expense base. Payroll, workload, coverage, and future-role evidence still need review, so treatment remains open rather than silently reducing or increasing adjusted EBITDA.
The three rows do not calculate a company subtotal. That restraint is intentional. The workpaper first makes the arithmetic, missing evidence, offsets, and operating questions reviewable. Only a later, purpose-specific analysis can decide which lines remain and how they affect a stated earnings basis. 24
Freeze each review version. Keep the source period, proposed by, checked by, status date, treatment rationale, and link to supporting records. If a line changes, retain the prior amount and reason rather than overwriting the history.
Add-back evidence room
This checklist prepares records and unresolved questions; it does not approve an adjustment or determine value.
- Source control: Tie each signed amount to one source account statement and period.
- Source control: Attach invoices payroll contracts payment proof and business-purpose records.
- Operating test: Review prior periods commitments root causes and replacement capacity.
- Operating test: Record recoveries related income downward corrections and missing costs.
- Review trail: Assign an owner reviewer status date rationale and limitation to every row.
- Review trail: Freeze each exported schedule and retain changes instead of overwriting history.
Carry an issue ledger into the broader earnings review
Close the schedule only when every line has a source, signed effect, period, event description, recurrence analysis, related offsets, counterfactual, owner, reviewer, and status. “Treatment open” is a valid result. It is more useful than a precise-looking adjusted subtotal built from unresolved rows.
Separate factual corrections from normalization judgments. A duplicate expense, posting error, or omitted credit may require the underlying books to be corrected. A valid recorded expense that may not continue is a different question. Keep the accounting decision, tax treatment, transaction adjustment, and valuation implication in separate fields.
Use the selected earnings basis consistently. If the schedule begins with reported EBITDA, reconcile every additional line from that same period. If another analysis begins with SDE, keep the source map and owner-role treatment distinct. Do not carry an adjustment across bases without showing where it already enters.
When owner economics are involved keep the SDE source calculation separatefrom adjusted-EBITDA treatment and replacement capacity.
The output should feed a broader quality-of-earnings review, not replace it. Revenue recognition, working capital, debt-like items, capital spending, customer concentration, and cash conversion can change the interpretation of earnings without appearing in an add-back schedule.
After the evidence file is controlled, decide what purpose it serves: internal planning, advisor discussion, valuation analysis, lender review, or buyer diligence. Record the purpose and limitations on every exported schedule. IVS documentation discipline makes those boundaries part of the work, not an appendix. 4
Use the reconciled schedule to continue to the private valuation pathwithout treating entered information as automatically verified.
Or use the private intake to frame a confidential owner conversationwithout uploading sensitive source records through the public site.
Questions owners ask
01Does EBITDA already include add-backs?
Basic EBITDA removes interest, income taxes, depreciation, and amortization from net income under the cited SEC terminology. Additional normalization produces a differently calculated measure that should be labeled distinctly, such as adjusted EBITDA, with the extra rows reconciled. That label does not approve any row. 2
02How many years should an add-back schedule reconcile?
03Must a buyer accept a documented add-back?
Sources and limits
- International Business Brokers Association — Glossary of Terms Used by Business Brokers and Advisors
Definitions of add-backs adjusted EBITDA and EBITDA in business-brokerage terminology. Limit: Not GAAP a valuation standard market evidence a transaction agreement or proof of buyer acceptance. Accessed 2026-07-21.
- U.S. Securities and Exchange Commission — Non-GAAP Financial Measures — Compliance and Disclosure Interpretations
EBITDA labels detailed reconciliation recurrence and period-consistency controls for registrants. Limit: Public-company disclosure guidance that does not govern a private sale approve add-backs or establish value. Accessed 2026-07-21.
- U.S. Securities and Exchange Commission — Conditions for Use of Non-GAAP Financial Measures
Comparable GAAP measure and clearly understandable quantitative reconciliation in covered public disclosures. Limit: Public-company rulemaking not a private-sale quality-of-earnings or adjustment standard. Accessed 2026-07-21.
- International Valuation Standards Council — What IVS asks of every business valuation
Purpose basis data provenance input reliability model responsibility documentation limitations and uncertainty. Limit: Supplies no accepted adjustment company value multiple or transaction outcome. Accessed 2026-07-21.
- Internal Revenue Service — What kind of records should I keep
Current source-document fields for business income expense payroll and asset records. Limit: Federal tax recordkeeping does not determine normalized earnings transaction treatment or value. Accessed 2026-07-21.
- Internal Revenue Service — Publication 583 — Starting a Business and Keeping Records
Period consistency source identification ledgers account descriptions and retained-record controls. Limit: Introductory federal tax guidance not company-specific accounting tax valuation or transaction advice. Accessed 2026-07-21.
Read the editorial standards or report a correction.